![](/img/cover-not-exists.png)
Phase I Study of MK-954, a New Angiotensin II Receptor Antagonist. Results of Single Oral Administration.
NAKASHIMA, Mitsuyoshi, KANAMARU, Mitsutaka, UEMATSU, Toshihiko, TAKAYAMA, Fumio, KAMEI, KazuoVolume:
26
Year:
1995
Language:
english
Journal:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
DOI:
10.3999/jscpt.26.671
File:
PDF, 2.63 MB
english, 1995